Unlock Discovery with Harmonized Data in the Cloud
Scientific innovation in today’s biopharmaceutical companies relies heavily on their ability to effectively manage big data across their organization, globally. The trend towards outsourcing vast amounts of work to contract research organizations (CRO’s) ...
Computer Software Assurance (CSA): The FDA’s New Approach to CSV
During a 2011 review of medical device quality data, the FDA’s Center for Devices and Radiological Health (CDRH) noticed a variety of widespread manufacturing risks that were impacting product quality. A few of these risks included...
Lab Integration with a Robust LIMS – What Can You Achieve?
With an integrated LIMS system, labs can save and manage large amounts of data that is collected from multiple facilities using a cloud-based platform. This data can be accessed real-time across the organization and also integrated with other departments.
New Veterinary Case Study Highlights Matrix Gemini LIMS as Key to Increasing Efficiency
Autoscribe Informatics has released a new veterinary laboratory case study focusing on the benefits that Matrix Gemini LIMS has bought to Scone Equine Hospital. The LIMS is in daily use in the largest equine veterinary practice in Australia.
Laboratory Informatics Weekly Update – Volume 19, Issue 29
July 21, 2021 Laboratory Informatics Weekly Update Volume 19, Issue 29 In This Issue Featured Books LIMSjournal - Summer 2021 Featured Content 07/21/2021 - Unlock Discovery with Harmonized Data in the Cloud Scientific innovation in today’s biopharmaceutical companies relies heavily on their ability to effectively manage big data across their organization, globally. The trend towards outsourcing vast amounts of work to contract research organizations (CRO’s) ... [Read More] 07/21/2021 - Abbott's Informatics Business Announces the Release of STARLIMS Technology Platform V12.2This highly anticipated release is a major step forward in the modernization of STARLIMS. Due to the unique design…Cross-border data transfer regulation in China
In this English review article published in the journal Rivista Italiana di Informatica e Diritto, University of Macerata's Yuan Li "aims to systematically and chronologically describe Chinese regulations for cross-border data exchange." Given the growth of cloud-based systems and data management of clients around the world, doing business with Chinese businesses and individuals requires a better understanding of transfer regulations in the country. Li first explains the concepts behind global data transfer and some of the agreements and soft laws that have sprung up as a result of increasing cross-border transfers, as well as the problems that arise. Li then goes into a detailed review of China's data protection laws, as well as how they are enforced and who enforces them. Then the author examines the data export regulations that have evolved in China. The conclusion is that there are still limitations to China's approaches to building a regulatory framework for data protection and transfer; however, "there are various positive dynamic developments in the framing of China’s cross-border data regulation." Yet further agreements with other nations will still depend on future developments in "multilateral trade and investment negotiations."
Why Should Clinical Diagnostics Labs Care About Ontology?
If your laboratory wants to scale throughput or make clinical breakthroughs, proper data management is critical in order to prevent the friction that will slow your organization down. But no conversation about data is complete without also considering the ontology used.
[Read More]
[Read More]
Clever admin tools for fast implementation
The last weeks I posted a few articles about QLIMS clever tools to speed up the implementation. Focus on QLIMS as a real SaaS or private Cloud implementation. What is still possible for a LIMS administrator in a cloud deployment? Way more than you think.
CSols Celebrates its 20th Anniversary
Celebrate, Good Times, Come On… It’s A Celebration! Those famous lyrics from the iconic 1980s hit by Kool and the Gang summarize how I feel right now! This month, CSols Inc. is celebrating 20 years of serving our employees, partners, and most importantly, you, our customers!
Top 3 Reasons to Invest in a LIMS
We all know that an investment in the right technology can create efficiencies for an organization. The COVID-19 pandemic highlighted the importance of managing the diagnostic testing laboratory using a comprehensive LIMS that is well-implemented and supported by a reputable LIMS vendor.
Laboratory Informatics Weekly Update – Volume 19, Issue 28
July 14, 2021 Laboratory Informatics Weekly Update Volume 19, Issue 28 In This Issue Featured Books The Complete Guide to LIMS and Laboratory Informatics: 2021 Edition Featured Content 07/14/2021 - Clever admin tools for fast implementationThe last weeks I posted a few articles about QLIMS clever tools to speed up the implementation. Focus on QLIMS as a real SaaS or private Cloud implementation. What is still possible for a LIMS administrator in a cloud deployment? Way more than you think. [Read More] 07/14/2021 - CSols Celebrates its 20th AnniversaryCelebrate, Good Times, Come On… It’s A Celebration! Those famous lyrics…Risk assessment of over-the-counter cannabinoid-based cosmetics: Legal and regulatory issues governing the safety of cannabinoid-based cosmetics in the UAE
In this 2021 article published in Cosmetics, Jairoun et al. describe the details of reportedly the first study in the United Arab Emirates (U.A.E.) "to measure to what extent topical cannabinoid-based consumer products contain undeclared tetrahydrocannabinol" (THC). Noting a lack of such studies in the U.A.E. as well as other parts of the world, the researchers used gas chromatography–mass spectrometry (GC-MS) to analyze 18 cannabinoid-based cosmetics manufactured in the U.S. and E.U. and sold in the U.A.E. to determine their undeclared THC and tetrahydrocannabinolic acid (THCA) content. After discussing their methodology, materials, and results, the authors conclude that with the discovery of "high levels of undeclared tetrahydrocannabinol" during their study, there is a real need for "cannabinoid-based cosmetic product producers to issue quality certificates ... [and provide] stricter monitoring and control regarding their [products'] safety and quality."
